Personalized Medicine in Oncology

Nowhere is the explosion in comprehensive genomic testing more evident than in oncology. Multiple consensus guidelines now recommend molecular testing as the standard of care for most metastatic tumors. To aid in the advancement of this rapidly changing field, we intend this Special Issue of JPM to...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Hōputu:	Online
Reo:	Ingarihi
I whakaputaina:	MDPI - Multidisciplinary Digital Publishing Institute 2022
Ngā marau:	patient-derived tumor xenograft (PDX) anti-cancer drug development immunodeficient mice precision medicine molecular profiling immunohistochemistry next-generation sequencing targeted therapy molecular oncology biomarkers molecular imaging non-small cell lung cancer proliferation cancer stem cells circulating tumour cells personalised treatment renal cell carcinoma clear cell VEGF immunotherapy PD-L1 immune checkpoint inhibitors immune checkpoint blockade tyrosine-kinase inhibitors integrin-linked kinase (ILK) ovarian cancer sgRNA gene expression microarray xenograft MTB cancer oncology practice community setting CGP pancreatic cancer FOLFIRINOX chemotherapy gender cholangiocarcinoma biliary tract cancer prognosis neutrophils BRCA1 BRCA2 PALB2 homologous recombination repair colorectal cancer heme oxygenase-1 endothelin-1 endothelin con-verting enzyme-1 bosentan precision oncology tumor-agnostic indications solid tumors tumor markers FDA-approved therapeutics n/a thema EDItEUR::M Medicine and Nursing
Urunga tuihono:	ONIX_20220224_9783036528205_71
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Me noho koe te mea tuatahi ki te waiho tākupu!

Personalized Medicine in Oncology

Ngā tūemi rite